Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Announces “Proactive” Approach To Rx-To-OTC Switches

This article was originally published in The Tan Sheet

Executive Summary

FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3

You may also be interested in...



FDA Budget Increases For OTC Drugs, Supplements Survive 2004 Process

Funding increases for OTC drug and dietary supplement activities at FDA are likely to see increased support from the Bush administration and Congress as the fiscal year 2005 budget process kicks off

FDA Budget Increases For OTC Drugs, Supplements Survive 2004 Process

Funding increases for OTC drug and dietary supplement activities at FDA are likely to see increased support from the Bush administration and Congress as the fiscal year 2005 budget process kicks off

FDA Budget Increases For OTC Drugs, Supplements Survive 2004 Process

Funding increases for OTC drug and dietary supplement activities at FDA are likely to see increased support from the Bush administration and Congress as the fiscal year 2005 budget process kicks off

Related Content

Topics

UsernamePublicRestriction

Register

PS095109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel